Precipio (PRPO) News Today → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free PRPO Stock Alerts $6.10 -0.19 (-3.02%) (As of 09:30 AM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 18 at 4:48 AM | americanbankingnews.comPrecipio (NASDAQ:PRPO) Shares Pass Above 200 Day Moving Average of $6.50May 15, 2024 | msn.comPRPO Stock Earnings: Precipio Misses EPS, Misses Revenue for Q1 2024May 10, 2024 | americanbankingnews.comPrecipio (NASDAQ:PRPO) Share Price Crosses Below 200 Day Moving Average of $6.57May 6, 2024 | globenewswire.comPrecipio Secures a short-term $500K Credit FacilityApril 20, 2024 | finance.yahoo.comPrecipio, Inc. (PRPO) Latest Stock News & Headlines - Yahoo FinanceApril 19, 2024 | morningstar.comPrecipio Inc PRPOMarch 25, 2024 | globenewswire.comPrecipio Announces Year end 2023 Shareholder Update CallMarch 12, 2024 | ca.finance.yahoo.comPrecipio, Inc. (PRPO)February 23, 2024 | benzinga.comPrecipio Stock (NASDAQ:PRPO), Analyst Ratings, Price Targets, PredictionsFebruary 13, 2024 | finance.yahoo.comPrecipio to Report $15.2M for FY-2023 (unaudited) Revenues, an increase of 60% YoYFebruary 6, 2024 | finanznachrichten.dePrecipio, Inc.: Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen Portfolio of Molecular assays for CancerFebruary 6, 2024 | marketbeat.comTrading was temporarily halted for "PRPO" at 10:02 AM with a stated reason of "LULD pause."January 23, 2024 | msn.comPrecipio’s Q4 cash burn from operations drops below $100K for full quarterJanuary 23, 2024 | finanznachrichten.dePrecipio, Inc.: Precipio's Q4-2023 Cash Burn From Operations (unaudited) drops below $100K for the full quarterJanuary 23, 2024 | finance.yahoo.comPrecipio’s Q4-2023 Cash Burn From Operations (unaudited) drops below $100K for the full quarterJanuary 17, 2024 | finanznachrichten.dePrecipio, Inc.: Precipio Signs Distribution Agreement For IV-Cell and HemeScreen in JapanJanuary 17, 2024 | finance.yahoo.comPrecipio Signs Distribution Agreement For IV-Cell® and HemeScreen® in JapanJanuary 17, 2024 | marketbeat.comTrading was temporarily halted for "PRPO" at 10:01 AM with a stated reason of "LULD pause."January 2, 2024 | finance.yahoo.comPrecipio Announces Christina Valauri joins the Board of DirectorsDecember 15, 2023 | finanznachrichten.dePrecipio, Inc.: Precipio Management Shares Thoughts on 2023, and Looks Ahead To 2024December 14, 2023 | finance.yahoo.comPrecipio Management Shares Thoughts on 2023, and Looks Ahead To 2024November 14, 2023 | marketbeat.comTrading was temporarily halted for "PRPO" at 11:11 AM with a stated reason of "LULD pause."October 18, 2023 | finance.yahoo.comPrecipio to Report $4.5M Q3-2023 Revenues, Double From Q3-2022October 3, 2023 | finanznachrichten.dePrecipio, Inc.: Precipio's Q3 Cash Burn From Operations (unaudited) Declines 59% YoY, from $2.5M in Q3-2022 to approximately $1M in Q3-2023October 3, 2023 | finance.yahoo.comPrecipio’s Q3 Cash Burn From Operations (unaudited) Declines 59% YoY, from $2.5M in Q3-2022 to approximately $1M in Q3-2023September 28, 2023 | finance.yahoo.comPrecipio Continues to Sign New HemeScreen™ CustomersSeptember 25, 2023 | finance.yahoo.comPrecipio Reduces Product Revenue Result Needed for Cash Flow BreakevenSeptember 22, 2023 | finanznachrichten.dePrecipio, Inc.: Precipio Takes Final Step Towards Regaining Nasdaq ComplianceSeptember 13, 2023 | finance.yahoo.comPrecipio’s Pathology Division Exceeds Breakeven Revenues in August, Four Months Ahead of PlanAugust 20, 2023 | finance.yahoo.comBroker Revenue Forecasts For Precipio, Inc. (NASDAQ:PRPO) Are Surging HigherAugust 19, 2023 | finance.yahoo.comPrecipio, Inc. (NASDAQ:PRPO) Q2 2023 Earnings Call TranscriptAugust 16, 2023 | benzinga.comPrecipio's Earnings: A PreviewAugust 13, 2023 | finance.yahoo.comPrecipio, Inc.'s (NASDAQ:PRPO) Shares Not Telling The Full StoryAugust 11, 2023 | finance.yahoo.comPrecipio Announces Q2-2023 Shareholder Update CallAugust 8, 2023 | finance.yahoo.comPrecipio Launches Its Much-Anticipated Quantitative BCR-ABL 2.0 PanelAugust 3, 2023 | finance.yahoo.comPrecipio’s Operational Efficiency Measures Continue To Reduce Cash Burn And Move The Company Towards BreakevenAugust 1, 2023 | investing.comEnd in sight for U.S. insider trading case over healthcare leaksAugust 1, 2023 | finance.yahoo.comPrecipio Unaudited Q2-2023 Revenues Show combined increase of 25% over Q1-2023July 6, 2023 | msn.comPrecipio (PRPO) Price Target Decreased by 29.82% to 2.04June 13, 2023 | finance.yahoo.comPrecipio Enters into Collaboration with Prestigious New York-based Institution to Develop Revolutionary Brain Tumor Panel using HemeScreen® TechnologyJune 8, 2023 | msn.comWhy Oxford Industries Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionJune 8, 2023 | marketwatch.comPrecipio Shares Slide Premarket on Sale of Equities >PRPOJune 8, 2023 | finance.yahoo.comPrecipio, Inc. Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private PlacementJune 7, 2023 | finance.yahoo.comProjected cash burn reduced by $1.5 million annually from Three Operational Efficiency ProjectsMay 17, 2023 | msn.comPrecipio GAAP EPS of -$0.13 misses by $0.02, revenue of $2.82M beats by $0.02MMay 17, 2023 | finance.yahoo.comPrecipio Shares Growth Catalysts For HemeScreenMay 15, 2023 | finance.yahoo.comPrecipio Announces Q1-2023 Shareholder Update CallMay 4, 2023 | finance.yahoo.comPrecipio Signs Another HemeScreen™ CustomerMay 4, 2023 | finance.yahoo.comPrecipio Adds Substantial Pathology Customer to its Diagnostic Services DivisionApril 27, 2023 | finance.yahoo.comPrecipio Granted 180-day Extension From NASDAQ To Regain Compliance Get Precipio News Delivered to You Automatically Sign up to receive the latest news and ratings for PRPO and its competitors with MarketBeat's FREE daily newsletter. Email Address Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow. Click here for your free guide PRPO Media Mentions By Week PRPO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PRPO News Sentiment▼-0.370.42▲Average Medical News Sentiment PRPO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PRPO Articles This Week▼30▲PRPO Articles Average Week Get Precipio News Delivered to You Automatically Sign up to receive the latest news and ratings for PRPO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Telesis Bio News Talis Biomedical News Accelerate Diagnostics News Cue Health News Singular Genomics Systems News Rapid Micro Biosystems News Galera Therapeutics News IM Cannabis News Universe Pharmaceuticals News Chemomab Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PRPO) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersDoes this make you sick?Allegiance GoldUrgent Nvidia WarningAltimetryThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarBill Gates is all about this tiny $2 stockTimothy SykesCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Precipio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
